Labcorp Holdings Inc. (LH) , or Labcorp’s strong focus on key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, is poised to help it grow in the upcoming quarters. The company maintains a solid pipeline of potential acquisitions that fit its financial strategy and will enhance its organic growth. The Central Laboratories business remains the key growth driver of the Biopharma Laboratory Services (“BLS”) segment. Meanwhile, the adverse impacts of macroeconomic issue ...